Eagle Pharmaceuticals, Inc.
Records under this name other than the patents Eagle Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 37 patents it holds.
Back to Eagle Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,803,762 | Ready-To-Use Bivalirudin Compositions now held by Sandoz Inc. In force · Medium confidence | In force | Medium confidence | |
| US 7,713,928 | Ready-To-Use Bivalirudin Compositions now held by Sandoz Inc. In force · Medium confidence | In force | Medium confidence | |
| US 12,582,633 | Methods of Treating Severe Acute Respiratory Syndrome now held by Cosette Pharmaceuticals, Inc. In force · High confidence | In force | High confidence | |
| US 12,605,364 | Methods of Treating SARS-COV-2 Infections now held by Cosette Pharmaceuticals, Inc. In force · High confidence | In force | High confidence | |
| US 8,815,833 | Stable amifostine liquid concentrate now held by Scidose, LLC Lapsed on the fee record Ended Aug 26, 2018 · High confidence | Lapsed on the fee record | Ended Aug 26, 2018 | High confidence |
| 12/394,431 | Topotecan Ready to Use Solutions Abandoned Abandoned Dec 12, 2014 | Abandoned | Abandoned Dec 12, 2014 | |
| 12/856,088 | Ready-To-Use Bivalirudin Compositions held by The Medicines Company and Eagle Pharmaceuticals, Inc. Abandoned Abandoned Jan 7, 2013 | Abandoned | Abandoned Jan 7, 2013 | |
| 12/885,009 | Formulations of Daptomycin now held by Scidose, LLC Abandoned Abandoned Apr 20, 2016 | Abandoned | Abandoned Apr 20, 2016 | |
| 13/767,672 | Formulations of Bendamustine Abandoned Abandoned Mar 6, 2017 | Abandoned | Abandoned Mar 6, 2017 | |
| 14/097,904 | Formulations of Bendamustine Abandoned Abandoned Jul 26, 2016 | Abandoned | Abandoned Jul 26, 2016 |